Executive Director, Medical Sciences
Hannah Hershoff (Yiqin Zhang), MD, PhD
Dr. Hershoff is an ophthalmologist and physician-scientist with more than 30 years of combined clinical practice and drug development experience. She has helped bring two ophthalmic therapies to market and has led global development of small-molecule and biologic programs from early discovery through late-stage clinical trials.
Before rejoining AiViva, Dr. Hershoff served as Vice President of Clinical Development at Lassen Therapeutics and Chief Medical Officer at Longwood Pharmaceuticals, where she directed clinical strategy, trial execution, in-licensing, and fundraising. Earlier, she was a Principal Investigator at the Novartis Institutes for BioMedical Research, contributing to the development of brolucizumab (Beovu) and ranibizumab (Lucentis).
She earned her M.D. from Jiangxi Medical School, M.S. in Neurology from Sun Yat-Sen University, Ph.D. in Experimental Ophthalmology from Lund University, and completed a postdoctoral fellowship at Harvard Medical School.